Shantha Biologics has secured a significant contract with Danish pharmaceutical giant Novo Nordisk to manufacture cartridges for injectable...

Wayve, a London-based innovator, is transforming the landscape of autonomous driving with its cutting-edge AI-driven machine learning frame...

India and Russia are deepening their space collaboration, with a significant push towards human spaceflight and cutting-edge launch systems...

Pope Leo's encyclical, 'Magnifica Humanitas', champions human dignity amidst AI advancements, reminding us of our inherent worth beyond pro...

IndiGo's Chief Human Resources Officer, Sukhjit Singh Pasricha, has resigned after an eight-year tenure, with Kanwal Jeet Singh Bakshi set ...

Hatred, a potent emotion, often arises from fear of the unknown, past hurts, jealousy, and group identity. Misunderstandings and a desire f...

Waaree Energies shares fell nearly 5% after a US Customs ruling triggered concerns over reputational impact despite the company’s clarifica...

Initial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...

Flesh-eating maggots, the New World screwworm, have reappeared in Texas and New Mexico, infecting livestock and at least one dog. Driven by...

Healthium Medtech's CEO Anish Bafna is transitioning to non-executive chairman as KKR-owned company seeks a new chief within a month. Bafna...

The Bombay High Court has cancelled Thane-based Menschlich Healthcare's trademark 'Duphachrit' in favour of Abbott Product Operations AG. T...

Indian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...

The benchmark snapped a four-day losing streak on Thursday, as ⁠investors digested the European Central Bank's rate hike and largely looked...

Britain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...

Danish drugmaker Novo Nordisk has confirmed a security incident. Unauthorised access to internal IT systems occurred. Certain non-public da...

India's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...

Novo Holdings is investing 500 million euros in the new Scaleup Europe Fund. This pan-European fund aims to support technology companies th...